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Infection of mice with lactic dehydrogenase virus  (LDV)  resulted in a  life- 
long elevation of a  number  of plasma enzymes including lactic dehydrogenase, 
isocitric dehydrogenase,  malic dehydrogenase,  phosphohexose  isomerase,  and 
glutamic-oxaloacetic transaminase  (1).  Recent  studies  on  the  mechanism  of 
enzyme elevation showed that infected mice cleared endogenous enzymes at a 
slower rate than uninfected mice (1). The present study was undertaken to see 
whether  the  catabolism  of  a  "nonenzymatic"  protein,  T-globulin,  was  also 
altered.  The  experiments  reported herein  show  that  the  catabolism of intla- 
venously administered I m  ~'-globulin was not impaired in virus-infected mice, 
but that the level of endogenous 3,-globulin was elevated, and that the capacity 
of the infected mouse  to produce antibody to a  heterologous protein  (human 
~'-globulin) was enhanced. 
Materials and Methods 
Animals.--Except where indicated otherwise,  conventional  CAF-1 male mice, 4 to 6 wk 
old, obtained from the animal production section of the National Institutes of Health (NIH) 
were used throughout these experiments.  Germfree male and female mice, 3 to 4 wk old, of 
the NIH stock colony were supplied by Dr. C. E. Miller of the Germfree Unit, Laboratory 
Aids Branch,  and were housed in plastic isolators (2) in the Gnotobiotic Section of the Na- 
tional Institute of Dental Research.  All materials introduced into the plastic isolators were 
treated so as to eliminate viable bacteria. To check for contamination, urine and feces were 
cultured twice a week. 
Virus.--The  method  of preparation and  the  assay for LDV  have been described  pre- 
viously (3). Stock pools P-16 and P-17 were used throughout these experiments.  The titer of 
the pools was approximately  10  l°.°IDs0/ml and all dilutions were made in Eagle's  basal medium 
or 0.85% sodium chloride (saline). Mice were infected routinely with LDV by injecting intra- 
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peritoneally 0.1  ml of a  10  -2 dilution of the stock virus. Prior to injection into germfree mice 
all preparations were passed through a 450 m# Millipore filter. 
Inactivation of Virus.--LDV was inactivated by treating a  10-  2 dilution of the stock virus 
with ether, heat, or ultraviolet light. Ether inactivation was performed as described earlier 
(3, 4). Heat inactivation was carried out by incubating the virus at 80°C  for 30 rain. Ultra- 
violet inactivation was performed with a  15 watt GE germicidal lamp placed 10 cm from an 
open 60 mm Petri dish containing 2.0 ml of the virus. The virus was exposed to the ultraviolet 
light for 2 min while undergoing constant agitation on a mechanical shaker. Following treat- 
ment all preparations were shown to be noninfectious. 
Immunodectrophoresis.--Immunoelectrophoresis  of  mouse  serum  was  carried  out  on 
standard microscope slides coated with 1.0% Ionagar No. 2 (Consolidated Laboratories, Inc., 
Chicago Heights, Illinois) in Veronal buffer (pH 8.4)  under a  constant current of 250 v  for 
90 min. Anti-mouse serum was prepared in rabbits by repeated injections of pooled normal 
mouse  sera in complete  Freund's adjuvant  (Difco Laboratories,  Inc.,  Detroit,  Michigan). 
Anti-mouse T-globulin serum  (goat) was obtained from Hyland Laboratories,  Los Angeles. 
The slides were photographed 48 hr after addition of the antiserum. 
Capillary Precipitins.--The amount of "}'-globulin in the serum of infected and uninfected 
germfree mice  was  determined by  mixing a  constant volume  of  undiluted  anti-mouse qc- 
globulin serum (goat) with serial twofold dilutions of mouse serum in saline. The results are 
expressed as the reciprocal of the highest dilution of mouse serum giving a visible precipitate 
in a capillary tube after refrigeration overnight. 
Hemagglutination.--The  antibody  titer  in  mouse  serum  following  immunization  with 
human "),-globulin was determined by the tanned cell hemagglutination technique of Boyden 
(5).  Three  concentrations  of  crystalline human "y-globulin  (4.0,  1.0, 0.25  mg)  were  used 
routinely to sensitize 1.0 ml of 2.5% sheep red blood cells.  Experiments to be reported sep- 
arately showed that it was necessary to screen our sera in this way since the concentration of 
human 3'-giobulin which gave the highest hemagghitination titer with 7S antibody (3'G) was 
not optimal for obtaining the highest titer with 19S antibody (3'M). The data reported in this 
paper were obtained from experiments in which 4.0 mg of human "y-globulin was employed to 
sensitize the sheep red blood cells. Hemagglutination titers were read as described by Stavitsky 
(6). To test for 19S antibody, the mouse serum was incubated at 37°C for 30 min in 0.1 M 2- 
mercaptoethanol (7) and then tested for loss of hemagghitinating activity. 
'y-Globulins.--For  the immunization and catabolism studies,  human T-globulin  (Cutter, 
Lot 6708), mouse 3'-globulin (Pentex, Lot 461) and rabbit ~/-globulin (Pentex) were used. Each 
preparation gave a single sharp band of precipitation in the 7 S 3'-globulin region when analyzed 
by immunoelectrophoresis. 
Measurement of Radioactivity.--~-Globulin  was labeled with I  TM by the iodine monochloride 
method of McFarlane  (8)  using approximately  1 mole of I  per mole of protein. Mice were 
injected intravenously or intraperitoneally with 0.5 to 2.0 #c of I131-1abeled protein in 0.2 ml 
saline. To reduce the uptake of 1131 by the thyroid gland, all mice were given, prior to and 
throughout  the experiment,  drinking water which contained 0.01%  KI  and  0.45%  NaC1. 
Whole body radioactivity was measured by a  gamma ray bulk spectrometer (Sharpe Labo- 
ratories, La Jolla, California) for 1 rain. A radioactive standard of each labeled protein was 
prepared in saline. The radioactivity of the standard and each animal was measured daily in 
the whole body counter and the values were corrected for physical decay of the isotope. The 
per cent of the radioactive protein remaining in the animal on each day was calculated and the 
results were plotted on semilog paper. 
~l-Globulin Catabolism.--The  catabolism of 3,-globulin in infected and uninfected animals 
was determined by injecting approximately 50/zg of I131-1abeled protein intravenously. The 
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from the graphic plot of the data. Mice were infected with LDV 1 day prior to injection of the 
labeled protein. 
lmmune Elimination.--The  rate of elimination of a labeled protein from the circulation has 
been used to measure an immune response  in rabbits by Talmage et al.  (9) and in mice by 
Dresser (10). In our experiments each animal was immunized intraperitoneally with 300 #g 
of T-globulin. At various times thereafter a tracer dose of IlSl-labeled protein (approximately 
20 #g) was injected intraperitoneally and the per cent of the radioactive protein remaining in 
each animal was  determined daily by whole body counting. Unless specified otherwise,  the 
animals were infected with LDV 1 day prior to immunization. 
Histologic Studies.--Germfree  mice were  infected with LDV and at various times there- 
after (1, 3, 6, I0, and 20 days) the cervical, mesenteric, lumbar, axillary, and inguinal lymph 
nodes and the spleen were removed. Specimens  obtained at the same time from uninfected 
germfree mice served as controls. The specimens were fixed in either neutral buffered formalde- 
hyde or Helly's solution, embedded in paraffin, sectioned at 4 #, stained with hematoxylin and 
eosin, and examined with a light microscope. 
RESULTS 
Elevation  of 7-Globulin  in  Virus-Infected  Mice.--The  effect  of LDV  on  the 
level of 5,-globulin in the serum of mice was studied by the capillary precipitin 
method.  Germfree  mice  were  employed in these  experiments  because  of  their 
low level of  T-globulin. As seen in Table I,  a  slight rise in T-globulin was  de- 
tected within 6 days after injection of LDV but was more marked at 10 and 20 
days.  Normal  mouse  plasma  or  virus  which  had  been  inactivated  by  heat, 
ether,  or ultraviolet light failed to produce any substantial rise in the level of 
T-globulin (Table II). Immunoelectrophoresis of serum obtained 10 days after 
injection of  LDV  showed  a  sizeable  precipitin  band  in  the  7S  region  while 
TABLEI 
~ter~T-~obulinin  ~rmfree Mouse ~raafterI~ection ~  LDV 
Time after injection 
days 
1 
2 
3 
4 
6 
10 
2O 
Injected withLDV 
<16 
<16 
<16 
<16 
32 
256 
512 
Titer* of "Y-globulin  in mouse sera~t 
Injected with normal 
mouse plasma 
ND§ 
ND 
ND 
ND 
<16 
<16 
16 
Noninjected 
ND 
ND 
ND 
ND 
<16 
<16 
<16 
* Reciprocal  of highest dilution of mouse sera giving a precipitate with goat anti-mouse 
T-globulin. 
:~ Pooled sera from groups of 4 to 5 mice. 
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serum from mice which  had  been injected with normal plasma or inactivated 
virus failed to show a  7S precipitin band (Text-fig. 1). 
Catabolism  of "y-Globulin  in  Infected  and  Uninfected  Mice.--Although  anti- 
viral antibody might be responsible for the increase in 3,-globulin noted above, 
TABLE II 
Titer of'g-Glob~din in Germfree Mouse Sera I0 Days after Injection  of Infectious and 
Noninfectious  Virus 
Treatment of LDV prior to inSection  Titer* of "Y-globulin  in mouse sera~ 
None 
Ether§ 
Heat§ 
Ultraviolet light§ 
Normal mouse plasma§ 
320 
40 
40 
80 
40 
* Reciprocal  of highest  dilution of mouse sera giving a precipitate with goat anti-mouse 
"g-globulin. 
:~ Pooled sera from groups of 4 to 5 mice. 
§ Preparations were tested and shown to be noninfectious. 
Text-Fig. 1.  Immunoelectrophoresis  of sera from  uninfected  and infected  (10 days post 
LDV) germfree mice. 
attempts  to  immunize  rabbits  and  guinea  pigs  with  LDV  (1,  11,  12)  or  to 
demonstrate neutralizing antibody in mice infected for  1 month  (13) have thus 
far been unsuccessful.  Furthermore, virus inactivated by ether, heat,  or ultra- 
violet light failed to raise the level of 3'-globulin in germfree mice. These findings 
together  with  the  recent  observation that  LDV-infected mice  cleared certain 
proteins (lactic dehydrogenase, etc.) at a  slower rate than uninfected mice (1), I~OTKINS, MERGEIqHAGEN,  RIZZO, SCHEELE~ AND WALDMANN  351 
suggested that the increase in "y-globulin might be due to impaired clearance of 
endogenous "y-globulin. To test this possibility, the catabolism of I~31-mouse 
"y-globulin was studied in infected and uninfected mice. As seen in Text-fig. 2, 
the rate of elimination of the tracer was the same in both groups. These findings 
argue  against  impaired  clearance  as  the  cause  of  the  elevated  "y-globulin. 
Similarly, the rate of elimination of human "y-globulin was found to be the same 
in the infected and uninfected mice for the first 4 days, but by day 6 the rate of 
elimination was markedly accelerated in the infected group (Text-fig. 3). The 
sudden elimination of the heterologous protein, but not the homologous pro- 
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Text-Fig. 2.  Catabolism of mouse 7-globulin (I  m) in infected and uninfected mice. Each 
group represents the average of 4  mice. 
tein,  suggested that  an  immune response had occurred  in the virus-infected 
mice. 
Accelerated lmmune Response to lteterologous Protein in Virus-Infected Mice.-- 
To study the  above  observation in more  detail, mice were  immunized with 
human "y-globulin. The animals were given a  tracer dose of the protein 5,  7, 
and 9 days later. Although animals immunized with human ,y-globulin elimi- 
nated the tracer somewhat more rapidly than unimmunized animals, it can be 
seen from the data in Text-fig. 4 that infection with LDV markedly accelerated 
the rate of antigen elimination. 
To test the immunologic specificity of the response, the rate of elimination 
of  Ira-human "y-globulin  was  compared  in  groups  of mice  which  had  been 
previously immunized with human or rabbit "y-globulin. As seen in Table III, 
mice immunized with human "y-globulin catabolized 91%  of the  Ira-human 
"y-globulin  within  24  hr,  whereas  mice  immunized  with  rabbit  "y-globulin 
catabolized only 27 %  of the labeled human "y-globulin. Similarly, I~-rabbit 352  '~t-GLOBULIN  AND  ANTIBODY  PRODUCTION  IN MICE 
"/-globulin  was  eliminated  more  rapidly  by  mice  immunized  with  the  ho- 
mologous protein. 
To substantiate further that the rapid elimination of the antigen in the virus- 
infected animal was due to antibody, sera was collected at different times after 
immunization from selected mice used in the immune elimination experiments 
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Text-Fig. 3.  Catabolism of human "),-globulin (I  lm) in infected and uninfected mice. Each 
group represents the average of 4 mice. 
(Text-figs. 4  to  6),  and was tested for hemagglutinating  antibody.  The data 
in Table IV show that antihuman "),-globulin was present in the serum of virus- 
infected  mice and was  in higher  titer  than in  the  serum of uninfected  mice. 
However, the antibody was present for only a short period of time and in some 
experiments was difficult to demonstrate. Further studies showed that the titer 
of the antibody was reduced to 10 or less following incubation with 2-mercapto- 
ethanol. 
Number of Mice Showing  an Immune Response.--The following experiment NOTKINS,  M~ERGENtL~GEN, RIZZO,  SCHEELE,  AND  WALDMANN  353 
was designed to determine how many animals actually showed an accelerated 
immune response following infection with  LDV. Mice were immunized with 
human 3,-globulin and 7 days later a tracer dose of I181-human "),-globulin was 
given. Elimination of 90 % of the tracer in 4 days or less was considered evidence 
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Text-Fig.  4.  Accelerated immune response  to  human 3'-globulin in  virus-infected mice 
Mice were immunized with human 3'-globulin on day zero. They were given a  tracer dose of 
the labeled protein (Hu 3'-I  l~l) 5, 7, and 9 days later and the rate of antigen elimination was 
followed.  Each group represents the average of 4 animals. 
for an immune response. As seen in Table V,  87 %  of the mice infected with 
LDV showed an immune response within 9 days after immunization as com- 
pared  to 4.7%  of the uninfected animals.  10 and  11  days postimmunization 
100% of the infected mice showed an immune response as compared to 23.8 
and 66.6 %, respectively, of the uninfected mice. Mice infected with LDV but 
not immunized with human "y-globulin failed to show any evidence of acceler- 
ated  antigen  elimination. 354  "y-GLOBULIN  AND  ANTIBODY  PRODUCTION  IN  MICE 
Rdationship  of Time of Infection to Immune Response.--In the previous ex- 
periments, mice were infected with LDV 1 day prior to immunization. To study 
the effect of chronic infection on the immune response, animals that had been 
TABLE III 
Specificity of Immune Response 
Immunized*, :~ 
None 
Human 3~-globulin 
Rabbit "},-globulin 
Per cent of Im 7-globulln catabolized within 24 hr 
after injection§ 
Challenged with 
Ira-human  3,-globulin  1  llaLrabbit  Tglobulin 
i 
25.2  [  19.8 
91.3  44.9 
27.1  93.7 
* Mice were immunized with 300/zg of human or rabbit "y-globulin on day zero and chal- 
lenged with a tracer dose (20 #g) of the labeled protein 9 days later. 
All animals were infected with LDV 1 day prior to immunization. 
§ Each group represents the average o[ 10 animals. 
TABLE IV 
Hemagglutinating Antibody in Mice Immunized wita Human "y-Globulin 
Hemagglutination titer 
Experiment  Experiment No. 1  Experiment No. 2  No. 3 
Group 
Days after immunization* 
11  16  12  24  12 
Immunized 
Uninfected 
Infected 
Unimmunized 
Uninfected 
Infected 
20 
320 
10 
ND 
10 
20 
ND~ 
ND 
80 
640 
20 
ND 
20 
10 
ND 
ND 
20 
40 
20 
20 
* Groups of 3 to 4 mice from the immune elimination experiments  (Figs. 4 to 6) were bled 
at various times after immunization and the titer of anti-human v-globulin in the sera was 
determined. 
ND, not done. 
infected with LDV 60 days earlier were employed. As seen in Text-fig. 5, the 
rate  of  immune  elimination in chronically infected animals was  considerably 
faster than in uninfected animals, but was not quite as rapid as in animals that 
had been infected 1 day prior to immunization. The data in Text-fig. 6 shows NOTKINS,  MERGENHAGEN, RIZZO,  SCHEELE,  AND  WALDMANN  355 
that when animals were infected with LDV 1 or more days after immunization, 
the accelerated immune response was substantially reduced or not apparent. 
ttistopathologic  Changes in  Virus-Infected  Mice.--The  elevated ~¢-globnlin, 
the increased level of antibody, the previously demonstrated  enlargement  of 
the spleen and lymph nodes (1), and the impairment of the reticnloendothelial 
system (RES) following infection with LDV (1, 31) led us to examine the spleen 
and lymph nodes of virus-infected mice for evidence of histopathology. Because 
of the virtual  absence of immunopathology in gerinfree  mice it was thought 
that  histologic  changes following  virus infection would be more apparent  in 
TABLE V 
Effect of LDV on the Time of Appearance and the Number of Mice Showing an 
Immune Response* 
Days post- 
immunization 
8 
9 
10 
11 
Normal 
Unlmmtmlzed 
No. IR~ 
0/18 
0/18 
0/18 
0/18 
% m§ 
Infected 
No. II~ 
No. Mice  % IR 
0/17  0 
0/17  0 
0/17  0 
0/17  0 
No. 11~ 
No. Mice 
0/21 
1/21 
5/21 
14/21 
* Mice were infected with LDV on the same day as or 
Immunized 
Normal  Infected 
No. IR 
%IR  No. Mice  %IR 
0  o/23  0 
4.7  20/23  87.0 
23.8  23/23  100.0 
66.6  23/23  100.0 
day prior to immunization 
with 300 #g of human v-globulin. They were challenged 7 days later with approximately 20 
/zg of I131-human 3,-globulin.  The disappearance of the tracer was followed daily. Elimination 
of 90% of the tracer in 4 days or less was considered evidence for an immune response (IR). 
The day on which the IR occurred was recorded. 
;~ Number of mice showing an immune response/total number of mice in the group. 
§ Per cent of mice in each group showing an immune response. 
these animals.  Our studies showed that  the splenic  white pulp of uninfected 
germfree animals consisted of densely packed, evenly distributed small lympho- 
cytes and was essentially free of germinal  centers (Fig.  1). The red pulp con- 
tained no plasma cells. The cortical nodules of the lymph nodes were almost 
exclusively of the primary type and consisted of closely packed small lympho- 
cytes (Fig. 3). In virus infected mice the spleen and lymph nodes were grossly 
enlarged.  Histologically, the most striking  alteration was the development of 
classical  germinal  centers.  These centers  appeared  as  circular  areas  of pale- 
staining  cells  surrounded  by a  band  of more  darkly  staining  lymphocytes 
(Figs.  2 and 4). Within the centers were large macrophages with cytoplasmic 
tingible  bodies, mitotic figures,  and  typical "blast"  cells with large,  slightly 
eccentric nuclei and basophilic cytoplasm (Figs. 5 and 6). Mature plasma cells, 
however, were not observed. The germinal  centers appeared within 6 days after 356  V-GLOBULIN  AND  ANTIBODY PRODUCTION IN  MICE 
infection but were more advanced and widespread by day 10. At 20 days the 
splenic white pulp had been obliterated almost completely by the development 
of germinal centers, and the enveloping collar of small lymphocytes had either 
disappeared  or  was  very thin.  Similarly,  the  cortical  nodules  of  the lymph 
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Text-Fig. 5.  Accelerated immune response in acutely and chronically infected mice. Num- 
bers in parentheses indicate that the mice were infected 1 or 60 days prior to immunization. 
Each group represents the average of 10 mice. 
nodes contained large germinal centers and the surrounding  lymphocytic band 
was thin and frequently incomplete. 
DISCUSSION 
Infection of mice with LDV raised the level of v-globulin and enhanced the 
animal's capacity to produce antibody to human v-globulin. The data suggests 
that the infectious virus acts as an adjuvant in that it shortens  the induction NOTKINS,  MERGENI-IAGEN,  RIZZO,  SCHEELE,  AND  WALDMANN  357 
period, raises the antibody titer, and increases the number of animals showing 
an immune response. 
Antibody to human -},-globulin was detected by both immune elimination and 
hemagglutination. On  the  basis  of  its  sensitivity to  2-mercaptoethanol,  the 
hemagglutinating  antibody  appears  to  be  of  the  ~'M-ty~pe. The  failure  to 
demonstrate  hemagglutinating antibody  in  some  experiments  and  its  short 
survival in others might be related  to  the  rapid  catabolism of ~'M  whch is 
thought to have a half-life of less  than 1 day (14-16)  and to the postulated 
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Text-Fig. 6.  Effect of LDV on the immune response in animals infected on the same day 
0,  1, 2,  or 6 days after immunization. Each group represents the average of 10 animals. 
cessation of ~,M-production in the  absence of constant antigenic stimulation 
(14, 17, 18). However, it should be emphasized that mercaptoethanol sensitivity 
is not a definitive test for the identification of ~'M-antibody since some prop- 
erties of ~,A- and ~,G- (7S)  antibody are also mercaptoethanol sensitive  (for 
references, see reference 19).  In fact, by immunoelectrophoresis we were able 
to show that infection of germfree mice with LDV did raise  the level of 7S 
"y-globulin. In this connection it is pertinent that Benedict (20) could not detect 
?S  antibody to bovine serum albumin in early primary rabbit  antisera if he 
used the hemagglutination technique, but was able to show 7S antibody if he 
employed the more sensitive ammonium sulfate salting-out procedure of Farr 
(21). In our experiments antibody to human ~'-globulin was detected by immune 
elimination long after it was possible to detect antibody by hemagglutination. 358  ~/-GLOBITLIN AND  ANTIBODY  PRODUCTION  IN ~[ICE 
In the absence of an adjuvant, it has been shown that immunization of mice 
by the intravenous or intraperitoneal route is relatively ineffective and tinder 
certain circumstances can lead to immunological tolerance rather than antibody 
formation  (10, 22-24).  In  our  experiments,  normal  mice  inoculated  intra- 
peritoneally with human T-globulin did show evidence of an immune response 
(Table V). The adjuvant effect of LDV greatly enhanced this response. How- 
ever, the effect of LDV on the immune response following different types, doses, 
and routes of antigen administration remains to be investigated. 
The increase in "pglobulin 6 to 10 days after infection of germfree mice was 
of particular interest, since neutralizing antibody to LDV was not found in mice 
infected for as long as  1 month (13)  nor in rabbits  and guinea pigs given 14 
bimonthly injections of the virus (12). Although the elevated ~,-globulin might 
represent nonneutralizing antibody or antibody of low avidity which is directed 
against the virus or a viral component, the increase in anti-human T-globulin 
described above makes it clear that LDV enhances the animal's immune re- 
sponse to a heterologous protein and thus acts as an adjuvant. This points to 
the possibility that the elevated ~/-globulin in the virus-infected germfree animal 
might represent an increase in so called "natural" antibody or antibody against 
unrecognized antigens. On the other hand, the virus might simply be stimulating 
the production of "nonantibody" "~'-globulin. Similar problems have been en- 
countered  in  other  systems  where  the  extent  of  the  increase  in  T-globulin 
following the administration of a known antigen and/or adjuvant could not be 
explained solely on the basis of neutralizing antibody directed against the in- 
jected materials (25-30). 
Since  earlier  experiments  showed  that  the  clearance  of  certain  proteins 
(lactic dehydrogenase, isocitric dehydrogenase, etc.)  was  impaired  following 
infection with LDV (1), we thought that the clearance of endogenous T-globulin 
might also be altered.  Studies with I1~l-7-globulin  showed that this was not 
the case, for infected and uninfected animals catabolized the labeled protein at 
the same rate. It must be emphasized that only the catabolism of 7S ~'-globulin 
was studied and whether LDV has any effect on the catabolism of other globu- 
lins is not known. If the increase in ~?-globulin is not due to altered catabolism 
then the virus must act by increasing the production and/or release of ~/-globu- 
lin.  Since  the spleen and lymph nodes contain antibody-producing cells,  our 
attention was directed to the possibility that changes produced in these organs 
by LDV was affecting the immune response. Several lines of evidence indicated 
that this was the case. First, these organs were found to be somewhat enlarged 
following infection with LDV (1, 11, 34). Second, the functional capacity of the 
RES was markedly altered in virus-infected animals  (1,  31).  Third, electron 
microscope studies revealed virus particles within peritoneal macrophages (32), 
and fourth, tissue culture experiments showed that the virus could grow in cells 
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rich in RES cells (1). In the present study we showed that the number of germi- 
nal centers was greatly increased following infection with LDV and that the 
time of appearance of these centers corresponded with the first noticeable rise in 
"~,-globulin. The virtual absence of germinal centers in germ_free mice as com- 
pared  to  the  large  number  normally present  in  conventional mice made  it 
possible  to  detect  and  follow  the  histopathology produced  by LDV.  Since 
germinal centers are  important sites of antibody production, the increase in 
the number of these centers in LDV-infected animals could account for the 
accelerated  immune  response  and  the  elevated  "y-globulin.  Studies  on  the 
temporal relationship between infection with LDV and injection of the antigen 
showed  that  an  accelerated  immune response  occurred  if  the  animals were 
infected prior to or within 1 day after administration of the antigen, but was 
greatly reduced or not apparent if animals were infected 2 or more days after 
administration of the  antigen. These preliminary studies suggest that LDV 
does not produce its adjuvant effect by stimulating antibody synthesis in cells 
already immunologically committed, but  acts  by  increasing  the  number  of 
noncommitted cells. A similar mechanism of action has been proposed for other 
adjuvants (35). 
Although an increase in the number of germinal centers appears to be the 
most likely explanation for the accelerated immune response, other factors also 
might play a role. First, the level of circulating antibody might be affected if 
the virus damaged antibody-producing cells  so as to release preformed anti- 
body. However, this seems unlikely since, as indicated above, injection of the 
virus into mice 2 or more days after immunization failed to raise the antibody 
level in these animals. Second, since macrophages are thought to play a  role 
in initiating antibody production (24, 36-39), the effect of LDV on these cells 
might affect the immune response. Third,  there is evidence in the literature 
which indicates that nucleic acids may act as an adjuvant (37, 40-45).  Since 
LDV is an RNA virus (4) which is continuously present in the circulation in 
high titer (3), it is possible that the RNA from the virus or virus-iv_fected cells 
might contribute to the accelerated immune response. 
At the present time, we can do no more than to speculate as to whether the 
ability of the infected animal to produce an accelerated immune response also 
increases its resistance to pathogens. Early in the course of infection a decrease 
in natural resistance would be expected because of the marked impairment of 
the RES (1, 31). However, the functional capacity of the RES as measured by 
carbon clearance returns to normal by the end of 1 week (1, 31). The increased 
antibody-producing capacity of the infected animal might thus outweigh the 
early deleterious effect of the virus and lead to a state of increased resistance. 
In  another  area,  viral  interference, the  accelerated immune response  of the 
LDV-infected animal might  also play a  role.  That  is,  LDV might interfere 
with the multiplication of a second virus by accelerating the antibody response 350  V-GLOBULIN AND ANTIBODY PRODUCTION IN MICE 
of the host to that virus. In addition, it is not unreasonable to suggest that LDV 
might  affect  other  immunologic  processes  such  as  homograft  rejection  and 
autoimmunity.  These  possibilities  are  particulally  important  in  light  of  the 
fact that many of the widely used transplanted mouse tumors and viruses are 
contaminated with LDV (1). Lastly, these studies point to the possibility that 
other viruses also might act as adjuvants. 
SUMMARY 
Infection of mice with  the ]actic dehydrogenase virus (LDV) resulted  in an 
elevated  level of "}'-globulin. Histologic examination  of the spleen and lymph 
nodes revealed  that  the  number of germinal  centers  was  greatly  increased. 
Immunization with human ")'-globulin  showed that the capacity of the virus- 
infected animal  to produce  anti-human "),-globulin was greatly enhanced  and 
that the virus  acted  as an adjuvant. From these experiments it is concluded 
that a virus infection (LDV) can affect the immunologic response of the host 
to a heterologous antigen. 
The authors wish to thank Dr. Robert Fitzgerald for the use of the germfree  facilities, and 
Miss Barbara Hopkins for her excellent technical assistance. 
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Fig.  1.  Spleen from a  germfree mouse. White pulp  (wp) appears uniformly dark 
owing to the large number of small lymphocytes and the absence of germinal  cen- 
ters. Hematoxylin and eosin.  ×  25. 
Fig. 2.  Spleen from a germfree mouse 20 days post LDV. Within the white pulp 
are many large pale-staining  germinal centers (gc) which are surrounded by a  thin 
band of darkly staining lymphocytes. Hematoxylin and eosin.  ×  25. 
Fig. 3.  Lymph node from a germfree mouse showing primary nodules (pn).  Ger- 
minal centers are absent. Hematoxylin and eosin.  ×  25. 
Fig. 4.  Lymph node from a  germfree mouse 20 days post LDV. Large germinal 
centers (gc) are present throughout the cortex. Hematoxylln and eosin.  X  25. 
Fig. 5.  Higher magnification of a germinal center from Fig. 2 showing macrophages 
with cytoplasmic tingible bodies.  Hematoxylin and eosin.  ×  293. 
Fig.  6.  Portion of a  geminal center from the  spleen  of an LDV-infected mouse 
showing mitotic figures  (m), "blast"  cells  (b), and a large macrophage (arrows) with 
cytoplasmic tingible bodies. Hematoxylin and eosin.  ×  1010. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  123  PLATE  50 
(Notkins et al.: 7-Globulin and  antibody production) 